Improvement in metabolic control of type 1 diabetes mellitus in a tertiary unit: 2005 vs 2012

Abstract

Type 1 Diabetes Mellitus (T1DM) is one of the most common chronic diseases of childhood and adolescence. The prevalence in younger than 15 years is predicted to rise by 70% from 2005 to 2020. Treatment of T1DM targets euglycemia and hemoglobin A1c (HbA1c) under 7.5%, if achieved without severe episodes of hypoglycemia (International Society for Pediatric and Adolescent Diabetes-ISPAD). It depends on insulin replacement and educational factors. The best metabolic control in both children and adolescents with T1DM is crucial to prevent long-term complications.